Skip to main content
  • For US Healthcare Professionals Only
  • Prescribing Information
    CIMZIA® (certolizumab pegol)
  • Sign In
  • Create account
For US Healthcare Professionals Only
Menu
Close
ucbcompass
  • Immunology
Close
ucbcompass
  • Home
  • Our Science
    • Clinical Trials
    • Disease Areas
    • Immunology Pipeline
    • Opportunities for Investigators
  • Scientific Education
    • Podcasts
    • Videos
  • Scientific Congresses
  • Medical Information
  • Professional Resources
    • For Dermatology
    • For Gastroenterology
    • For Rheumatology
  • Prescribing Information
    • CIMZIA® (certolizumab pegol)

Dermatology Resources

Contents

Clinical Reference Tools Evidence-Based Practice Resources Professional Social Networks

Clinical Reference Tools

Medscape
MotherToBaby
PubMed (Medline)®

Evidence-Based Practice Resources

American Academy of Dermatology (AAD) Clinical Practice Guidelines

Professional Social Networks

Doximity
SERMO
You are now leaving UCBCOMPASS®

UCBCOMPASS® offers links to third party websites provided solely for your convenience that may assist you in locating other useful information. UCB is not responsible for content or privacy policies on linked third-party websites that are not under the control of UCB.

Do you wish to continue?

Cancel

Forgot Password

Please enter the email address associated with your UCBCOMPASS® account.

Password reset instructions will be mailed to your registered email address.

If you no longer use the email associated with your account, please contact ucbcompass@ucb.com for further support.

ucb_logo_2x

This site is intended for Healthcare Professionals licensed in the United States.

UCBCOMPASS® provides accurate, unbiased, and non-promotional scientific education and medical information on UCB products and disease areas of focus. This content is for informational purposes only and is not intended as medical advice. It may include information about products or uses that have not been approved by the U.S. Food and Drug Administration.

Notice about cookies
This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy.

By clicking “Confirm” I certify that I am a U.S. Healthcare Professional and have read and consent to this site’s use of cookies.
I am a patient or caregiver
I am a non-U.S. Healthcare Professional

Sign in

User login

Forgot password?

Create a UCBCOMPASS® Account

  • Quickly access recent medical and scientific information
  • Save content to your personal library
  • Receive update alerts on content of interest
Get Started
UCB Compass
  • Submit Feedback
  • Site Map
  • Contact Us
  • UCB.com
  • UCB-USA.com
  • ucbCARES®
UCB | Inspired by patents. Driven by Science.

CIMZIA® is a registered trademark and UCBCOMPASS®  is a trademark of the UCB Group of Companies. All other trademarks and registered trademarks are the property of their respective holders.

©2019 UCB, Inc. All data collected on this site is governed by UCB's Privacy Policy, Cookies Policy as well as the site Terms and Conditions. This site is intended for US Healthcare Professionals only.

US-S-BK-1900002

Adverse Event

Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which may or may not have a causal relationship with this treatment.

Additional safety information includes (but is not limited to) the following report types:

  • Unapproved or off-label use
  • Use during pregnancy
  • Exposure to a drug during breast-feeding / lactation
  • Overdose (whether intentional, accidental or prescribed)
  • Drug abuse or misuse
  • Medication errors
  • Drug-drug interactions
  • Drug-food interactions
  • Lack of therapeutic effect